A carregar...
Acute inflammatory thyromegaly following checkpoint inhibition: A new imaging entity?
Immune checkpoint blockade (CPB) utilizing such agents as ipilimumab, nivolumab, or pembrolizumab has revolutionized melanoma therapy and has seen continued utilization in numerous other malignancies in recent years. However, these agents come at the price of inflammatory immune-related adverse even...
Na minha lista:
| Publicado no: | Radiol Case Rep |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5850905/ https://ncbi.nlm.nih.gov/pubmed/29552247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radcr.2017.09.008 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|